Category: Clinical trials

Sanofi and Regeneron Announce Positive Phase 2 Top-line Dupilumab Results in Patients with Chronic Sinusitis with Nasal Polyps

Paris and Tarrytown, N.Y. – September 30, 2014 - Sanofi and Regeneron Pharmaceuticals, Inc. today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and...